Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
COCH 
Envoy Medical Inc. (COCH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: COCH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $6.88
1 Year Target Price $6.88
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -80.17% | Avg. Invested days 38 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 28.62M USD | Price to earnings Ratio - | 1Y Target Price 6.88 |
Price to earnings Ratio - | 1Y Target Price 6.88 | ||
Volume (30-day avg) 4 | Beta 2.18 | 52 Weeks Range 1.06 - 3.99 | Updated Date 09/16/2025 |
52 Weeks Range 1.06 - 3.99 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.41 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -6500% |
Management Effectiveness
Return on Assets (TTM) -148% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 52384048 | Price to Sales(TTM) 129.9 |
Enterprise Value 52384048 | Price to Sales(TTM) 129.9 | ||
Enterprise Value to Revenue 235.96 | Enterprise Value to EBITDA -1.35 | Shares Outstanding 21520900 | Shares Floating 10852576 |
Shares Outstanding 21520900 | Shares Floating 10852576 | ||
Percent Insiders 49.46 | Percent Institutions 59.25 |
Upturn AI SWOT
Envoy Medical Inc.
Company Overview
History and Background
Envoy Medical Inc. is a medical device company focused on developing innovative implantable neurostimulation systems to treat certain neurological conditions. It was founded in 2007 and is headquartered in White Bear Lake, Minnesota. The company's focus has been on developing fully implantable auditory devices, designed to restore hearing for individuals with sensorineural hearing loss.
Core Business Areas
- Hearing Restoration Devices: Design, development, and commercialization of fully implanted hearing devices, aiming to provide a natural and discreet hearing experience. This includes their Esteemu00ae system and potential future innovations in the field.
Leadership and Structure
Details on specific leadership are limited. As a smaller company, it typically has a CEO and a management team overseeing key functions such as engineering, R&D, operations, and marketing. The organizational structure is likely functional, with departments reporting to senior leadership.
Top Products and Market Share
Key Offerings
- Esteemu00ae: A fully implantable hearing device designed to restore natural hearing. It uses the body's own ear to amplify sound, without external components. Market share data is difficult to obtain for the Esteem due to its niche market. Major competitors include companies with Cochlear Implants (Cochlear Ltd.) and Bone Anchored Hearing Aids (BAHA) (Demant A/S).
Market Dynamics
Industry Overview
The hearing aid industry is driven by an aging population, technological advancements, and increasing awareness of hearing loss. The industry includes hearing aids, cochlear implants, and bone-anchored hearing aids. Innovation focuses on miniaturization, improved sound quality, and connectivity.
Positioning
Envoy Medical occupies a niche position focusing on fully implantable devices. This differentiates them from traditional hearing aid manufacturers. Their competitive advantage lies in the discreet nature and natural sound quality offered by their device.
Total Addressable Market (TAM)
The global hearing aid market is estimated to be around $10 billion USD. Envoy Medical is positioned to capture a portion of this market with its Esteem device, focusing on individuals seeking a discreet and potentially more natural hearing solution. Their potential share of the TAM depends on their ability to scale production, expand market reach, and demonstrate the long-term benefits of their technology.
Upturn SWOT Analysis
Strengths
- Unique and innovative technology (fully implantable)
- Discreet design
- Potential for natural sound quality
- Focus on a specific niche within the hearing aid market
Weaknesses
- Limited market presence compared to major hearing aid manufacturers
- High cost of the device
- Surgical procedure required for implantation
- Dependence on a single product (Esteemu00ae)
Opportunities
- Expanding market reach through partnerships and distribution agreements
- Developing next-generation implantable hearing devices
- Increasing awareness of the benefits of implantable hearing solutions
- Addressing unmet needs in specific patient populations
Threats
- Competition from established hearing aid manufacturers
- Technological advancements in traditional hearing aids
- Regulatory hurdles and reimbursement challenges
- Potential for adverse events associated with the surgical procedure
Competitors and Market Share
Key Competitors
- COCH
- DEMANT.CO
Competitive Landscape
Envoy Medical's advantage is its fully implanted design, offering discretion. However, its disadvantages include a higher cost and surgical requirement compared to conventional hearing aids. Cochlear implants provide a more effective option for profound hearing loss cases.
Growth Trajectory and Initiatives
Historical Growth: Limited historical growth data is available.
Future Projections: Future growth will depend on the success of Esteem and the development of new products. Analyst estimates are unavailable. Projected growth will heavily depend on the successful scale-up and market acceptance of their fully implanted hearing solution.
Recent Initiatives: Likely includes securing regulatory approvals for Esteem in new markets, expanding their sales and marketing efforts, and investing in research and development for future products.
Summary
Envoy Medical is a company with a unique fully implanted hearing device, offering a discreet solution. Its success hinges on overcoming challenges such as high cost, surgical requirements, and competition from established players. Future success will depend on effective marketing, expanding market reach, and continued innovation. Securing regulatory approvals and demonstrating long-term value are vital. The company will need to address its niche placement within the hearing industry to become more dominant.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Market Research Reports
- SEC Filings (if available)
Disclaimers:
The information provided is based on available data and may be incomplete or inaccurate. Market share data is estimated. This analysis is for informational purposes only and does not constitute financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envoy Medical Inc.
Exchange NASDAQ | Headquaters White Bear Lake, MN, United States | ||
IPO Launch date 2021-04-29 | CEO & Director Mr. Brent T. Lucas Esq. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 42 | Website https://www.envoymedical.com |
Full time employees 42 | Website https://www.envoymedical.com | ||
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.